The Amsterdam District Court has delivered a ruling in the lawsuit brought by Farma ter Verantwoording (FtV) — The ...

South Korean biotech Illimis Therapeutics has raised 58 billion won ($42 million) in a series B round to advance its GAIA ...

China’s vaccine landscape is shifting after local biotech Xiamen Innovax Biotech unveiled the country’s first domestically ...

China-based biotech CARsgen Therapeutics (HKEX: 2171) has strengthened its grip on intellectual property in the CAR-T space ...

UK pharma major AstraZeneca today announced positive high-level results from the baxdrostat BaxHTN Phase III trial in ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the use of Lynkuet (elinzanetant) for the ...

German family-owned pharma major Boehringer Ingelheim and Denmark’s LEO Pharma today announced an exclusive global license ...

Japanese drugmaker Eisai today revealed that it has launched its Urece (dotinurad) in China as a treatment for gout. Urece ...

Even as the US Food and Drug Administration (FDA) has unveiled a strategic expansion of its oversight mechanisms for foreign ...

South Korea’s Samsung Bioepis today published a whitepaper titled ‘Solving the Biosimilar Void in Europe’ that proposes ...

Ultragenyx Pharmaceutical (Nasdaq: RARE) has been dealt a regulatory setback, as the American medicines regulator has ...

New figures in Danish pharma trade group Lif's Medicine Reimbursement Meter show a slight increase in the number of pharmacy ...